Beyond Statins: Dr. Payal Kohli on Modern Lipid Therapy

In this wide-ranging discussion, Payal Kohli, MD, emphasizes the importance of considering non-statin lipid-lowering therapies—particularly in high-risk groups such as patients with ASCVD and high-risk diabetics—for optimal cardiovascular risk reduction.

Editorial Board

Expert Interviews on Cardiology

;